Human Cannabinoid Pharmacokinetics

Cited by (1,000)

Items 801–900 of 1,000

1. Delays in blood collection and drug toxicology results among crash-involved drivers arrested for impaired driving
   Jana M. Price, Ryan C. Smith, Amy Miles, Turan A. Kayagil · 2024 · Traffic Injury Prevention
2. Development of Delivery Systems with Prebiotic and Neuroprotective Potential of Industrial-Grade Cannabis sativa L.
   Szymon Sip, Anna Stasiłowicz-Krzemień, Anna Sip, Piotr Mirosław Szulc, Małgorzata Neumann, Aleksandra Kryszak, Judyta Cielecka‐Piontek · 2024 · Molecules
3. Evaluation of Cannabis Per Se Laws: A Semi‐Mechanistic Pharmacometrics Model for Quantitative Characterization of THC and Metabolites in Oral Users
   Peizhi Li, Guohua An · 2025 · The Journal of Clinical Pharmacology
4. Cannabidiol from Cannabis sativa L. Herbal Extract as an Bioactive Factor in Polysaccharide Coatings with Antioxidant Properties for Extended Food Quality
   Renata Dobrucka, Mikołaj Pawlik, Marcin Szymański · 2025 · Materials
5. Daily Use of a Broad-Spectrum Cannabidiol Supplement Produces Detectable Concentrations of Cannabinoids in Urine Prohibited by the World Anti-Doping Agency: An Effect Amplified by Exercise
   Scott H. Gillham, Paige L. Cole, Daniel J. Owens, Neil J. Chester, Theodoros M. Bampouras, Danielle McCartney, Rebecca Gordon, Iain S. McGregor, Graeme Leonard Close · 2025 · Medicine & Science in Sports & Exercise
6. An in vitro experiment on the interaction of charcoal or wheat bran with 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and its glucuronide
   Gisela Skopp, Gerd Mikus · 2013 · Analytical and Bioanalytical Chemistry
7. Retinal Ganglion Cell Dysfunction in Regular Cannabis Users
   Christopher J. Lyons, Anthony G. Robson · 2016 · JAMA Ophthalmology
8. Türkiye Pazarında Yeni Bir Ürün: Kenevir Özütlü Soğuk İçecekler
   Melike Aydoğdu, Rukiye Döğer, Serap Annette Akgür · 2017 · The Bulletin of Legal Medicine
9. An (Un)Fortune Cookie
   Nir Friedman, Jessica Gantz, Yaron Finkelstein · 2017 · Pediatric Emergency Care
10. Cannabinoids Determination in Brain: A Supplemental Helpful in Postmortem Evaluation
    Federica Palazzoli, Anna Laura Santunione, Filippo Marchesi, Patrizia Verri, Daniele Vandelli, Manuela Licata, Enrico Silingardi · 2020 · Journal of Analytical Toxicology
11. Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
    STEVEN P. JAMES · 2020 · Cambridge University Press eBooks
12. Cannabinoids in the Treatment of Epilepsy: A Review
    Daniel J. Zhou, Erin Dennis, Isha Snehal, Arun Swaminathan · 2021 · European Medical Journal
13. Driving under the influence of cannabis: A 5-year retrospective Italian study
    Donata Favretto, Cindi Visentin, Anna Aprile, Claudio Terranova, Alessandro Cinquetti · 2023 · Forensic Science International
14. Drug interactions with Cannabis sativa: Mechanisms and clinical implication
    Atena Hasanpoor, Maryam Akaberi, Prashant Kesharwani, Zahra Sobhani, Amirhossein Sahebkar · 2023 · Annales de Toxicologie Analytique
15. The effects of Cannabis compounds (THC, CBD, and THC-COOH) on Sperm Motility in Male Participants: A Prospective Study
    Ayham Ismaeil, Peter Michael Jankowski, Riffat Bibi, Mohamad Eid Hammadeh, Houda Amor · 2023 · International Journal of Women s Health and Reproduction Sciences
16. High Stakes: Exploring the Impact of Cannabis Use in Pregnancy and Lactation
    Erica M. Wymore, Katharine Wagner, Cecille Gold, Laurie Seidel Halmo · 2025 · NeoReviews
17. Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review
    Paul J. Christo, Eugene Vortsman, Christopher G. Gharibo, Jo Ann LeQuang, Joseph V. Pergolizzi · 2025 · Cureus
18. Cannabis-Impaired Driving in Canada: Methodological Challenges and Emerging Research Priorities
    Michael T Amlung · 2018 · The Canadian Journal of Addiction
19. Secondhand marijuana smoke (SHMS): Exposure occurrence, biological analysis and potential health effects
    Binnian Wei, Danielle M. Smith, Mark J. Travers, Richard J. O’Connor, Maciej Lukasz Goniewicz, Andrew J. Hyland · 2019 · Advances in molecular toxicology
20. Review of Medicinal Use of Cannabis Derivatives and the Societal Impact of Legalization
    Akshat Malik, K. Fatehi, N. Menon, P. Chaturvedi · 2020 · Indian Journal of Palliative Care
21. Impact of Lowering Confirmatory Test Cutoff Value in Pre-Enlistment Urine Cannabinoids Screening: About Five Years' Experience in the French Gendarmerie
    Yannick Lecompte, M. Perrin, S. Salle, Olivier Roussel · 2012 · Journal of Analytical Toxicology
22. Effects of drugs of abuse on channelrhodopsin-2 function
    Dominic A. Gioia, Minfu Xu, Wesley N. Wayman, John J. Woodward · 2018 · Neuropharmacology
23. Daring discourse – yes: practical considerations for cannabis use in the perioperative setting
    Hance A. Clarke, Priodarshi Roychoudhury, Karim Shiraz Ladha, Timothy Sean Leroux, Joseph Fiorellino, Alexander Huang, Lakshmi P. Kotra · 2020 · Regional Anesthesia & Pain Medicine
24. Cannabinoids and the Adolescent Patient: A Pragmatic Guide for Pediatric Practitioners
    Gregg Joseph Montalto, Elizabeth G. Cius, Maria Hughes Rahmandar · 2021 · Pediatric Annals
25. Cannabis Drug Interactions
    George Polson, Matthew J. Chung, Salman Hirani, Christina Le-Short · 2021 · Springer eBooks
26. Overview of Medicinal Cannabis
    Kylie O’Brien, Philip Blair · 2021 · Springer eBooks
27. Cannabidiol Does Not Cause Significant Changes to Working Memory Performance in the N-Back Task
    Éamon Jones, Styliani Vlachou · 2021 · Pharmaceuticals
28. Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects
    Danial Schecter, Claude Cyr · 2022 · Springer eBooks
29. Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs
    Edward James, Thomas L Robertshaw, Michael J Pascoe, Fiona Chapman, Andrew D. Westwell, Andrew Paul Smith · 2019 · Drug Science Policy and Law
30. Effect of regular marijuana smoking on platelet function
    Yalçın Gölcük, Burcu Gölcük, Semih Sözen · 2015 · The American Journal of Emergency Medicine
31. The Impact of Hemp Seed Oil on Drug-Drug Interactions: A Comprehensive Review of Potential Mechanisms and Clinical Implications
    Shahabaddin Solaimanian, Bita Rahmani, Mohammad Reza Shiri‐Shahsavar · 2023 · Research Square
32. A two-sample approach to retrograde extrapolation of blood THC concentrations – Is it feasible?
    Peder Olai Skjeflo Holman, Gudrun Høiseth, Liliana C. Bachs, Cecilie Hasselø Thaulow, Merete S. Vevelstad, Jørg Gustav Mørland, Maren Cecilie Strand · 2023 · Forensic Science International
33. Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain
    Yu Wang, Xinzhen Fu, Meihua Zheng, Qian Liu, Hailin Gan, Zeyu Song, Mingyan Yang, Ke Liu, Zeping Xie, Huaying Fan · 2024 · European Journal of Pain
34. Haven't I waited long enough? The role of wait times and subjective impairment in cannabis-related driving behavior
    Ayelet Har-Even, Nehama Lewis, Hadar Eliash, Sharon R. Sznitman · 2024 · International Journal of Drug Policy
35. Metabolic fate of drugs of abuse and new psychoactive substances: A pilot study on a novel workflow using a zebrafish embryo model combined with human microdosing
    Simon K. Wellenberg, Tanja M. Gampfer, Lea Wagmann, Philip Schippers, Jennifer E. Herrmann, Rolf Müller, Folker Westphal, Markus Robert Meyer · 2025 · British Journal of Clinical Pharmacology
36. Pharmacokinetics of cannabidiol and its two main phase I metabolites in Connemara ponies
    Kata Wermer, Orsolya Korbacska‐Kutasi, Róbert Berkecz, Dezső Csupor, Nóra Ágh, Anita Sztojkov‐Ivanov, Dániel Cserhalmi · 2025 · Frontiers in Veterinary Science
37. Divergent outcomes of delta 9 – tetrahydrocannabinol (THC) in adolescence on mesocortical dopamine and cognitive development in male and female mice
    Tanya Capolicchio, Giovanni Hernández, Sammy Shun Wai Shi, Emilie Dube, Katherina Estrada, Michel Giroux, Brian J. Nieman, Zdenka Pausová, Cecilia Flores · 2025 · Psychopharmacology
38. Influence of Different Amino Acids on the Aerosolization, Stability and Cytotoxicity of Spray-Dried Cannabidiol Dry Powder for Inhalation
    Komal Komal, Lyall R. Hanton, Michelle Glass, Shyamal C. Das · 2025 · Pharmaceutics
39. Should cannabis be used in the management of endometriosis?
    Mike Armour, Justin Sinclair, Callie Seaman, Amelia K. Mardon, Toobah Farooqi, Orit Holtzman, Mathew Leonardi · 2025 · Expert Review of Endocrinology & Metabolism
40. Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal Surgery
    Elliott J. Yee, Michael J. Kirsch, Owen S. Miller, Cristina Sempio, Jacquelyn L. Bainbridge, Jost Klawitter, Uwe Christians, Helen J. Madsen, Martin D. McCarter, Ana Gleisner et al. · 2025 · Annals of Surgical Oncology
41. Cannabinoid Vaping Products: Regulation, Composition, Toxicological Effects, and Emerging Research
    Charlotte A. Love, Ned A. Porter, Hye‐Young Kim, Ilona Jaspers · 2025 · Chemical Research in Toxicology
42. Derivation of a health‐based guidance value for Δ8‐tetrahydrocannabinol (Δ8‐THC) and its occurrence in food
    EFSA Panel on Contaminants in the Food Chain (CONTAM), Helle Katrine Knutsen, Agneta Åkesson, Vasileios Bampidis, Margherita Bignami, James Kevin Chipman, Gisela H. Degen, Antonio F. Hernández, Timothy P. Hofer, Christer Högstrand et al. · 2025 · EFSA Journal
43. Pharmacoepidemiologic characterization of cannabis use and symptomatology in rheumatology using natural language processing of electronic health record clinic notes
    Titilola Falasinnu, Nathan Le, Yiyu Wang, Aishwarya Alagappan, Andrew L. Walker, Tricia Park, Jerik Leung, Yashaar Chaichian, Michael H. Weisman, Martha O Kenney et al. · 2025 · Journal of Pain
44. Cannabis produces acute hyperphagia in humans and rodents via increased reward valuation for, and motivation to, acquire food
    Catherine Hume, Carrie Cuttler, Samantha L. Baglot, Lucia Javorcikova, Ryan J. McLaughlin, Matthew N. Hill · 2025 · Proceedings of the National Academy of Sciences
45. Hemp versus marijuana: Chemistry- and pharmacology-associated regulatory framework
    Layan Razouk, Rania Hamdy, Abdalla Ahmad, Osama Razouk, Nashwa Ahmed Mohamed, Sameh S. M. Soliman · 2026 · Medicine Science and the Law
46. Potency-related effects of smoked cannabis on simulated driving performance: a randomized, controlled crossover trial
    Bruna Brands, Adam Zaweel, Madison Wright, Patricia Di Ciano, Christine M. Wickens, Justin Matheson, Andrew Fares, Omer S. M. Hasan, Marcos Sanches, Beth Ann Sproule et al. · 2026 · Scientific Reports
47. Pharmacokinetic Differences Between Fast-Acting, Standard, and Placebo Cannabis Edibles
    Bradley T. Conner, Emma E. Smith, Samuel M. DiCecco, Kira L. Sturgess, Hollis C. Karoly, Gregory Dooley, Natalie Akagi, Charles Villanueva, Michael Hennesy · 2026 · Cannabis and Cannabinoid Research
48. Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration
    Daniel K. Fowler, Tylor M. Savage, Duncan Ian Mackie · 2026 · Journal of Cannabis Research
49. Mind the Gap: Unraveling the Pharmacokinetic Variability of Δ9‐Tetrahydrocannabinol (THC)
    Shi Lu, Xin Liu, Linda Truong, Zheng Liu, Fei Guo, Jennifer H. Martin, Xiao Zhu · 2026 · The Journal of Clinical Pharmacology
50. Effects of repeated cue exposure on cannabis craving
    Jessica S. Fogel, Thomas H. Kelly, Arit M. Harvanko, Joshua A. Lile · 2015 · Drug and Alcohol Dependence
51. Supercritical carbon dioxide Cannabis sativa L. and Humulus lupulus extracts and their influence on human macrophages inflammatory state*
    Aleksandra Gregorius, Wojciech Krzyczkowski, Marta Wierucka, Julia Kupińska, Agnieszka Dębczak, Urszula Łopatek, Katarzyna Tyśkiewicz, Rafał Wiejak, Olga Wrona, Edward Rój · 2019 · Postępy Higieny i Medycyny Doświadczalnej
52. Phytocannabinoids: Cannabidiol (CBD)
    Priodarshi Roychoudhury, Ning Nan Wang, Samer Narouze · 2021 · Springer eBooks
53. Increased identification of cannabis use among drivers involved in motor vehicle collisions using an expanded cannabis inventory
    Esther K. Choo, Stacy A. Trent, Daniel K. Nishijima, Ariane Audett, Robert G. Hendrickson, Angela H. Eichelberger, Karen J. Brasel, Yu Ye, CHERYL J. STEPHENS CHERPITEL · 2022 · Academic Emergency Medicine
54. Approaches to Measuring Cannabis Use in Injury Research: Beyond Drug Detection
    Ashley Brooks‐Russell, Richard Holdman, Jennifer M. Whitehill · 2022 · Current Epidemiology Reports
55. Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology
    Tiffany Y-C Tang, Justin S Kim, Aditi Das · 2023 · Advances in pharmacology
56. Medical Implications of Marijuana and Cannabis-Derived Products
    Arjavon T Talebzadeh · 2023 · Applied Cell Biology
57. Cannabis regulatory system in European Union countries, forensic concept of “doping dose” and medico-legal implications
    Andrea Cioffi, Camilla Cecannecchia, Maria Chiara David, Luigi Cipolloni, Alessandro Santurro · 2023 · Medico-Legal Journal
58. Colorado drugged driving prevalence and impaired driving conviction rates: Effects of impaired driving definitions and a 5-nanogram limit for delta-9 tetrahydrocannabinol
    Ed Wood · 2024 · Traffic Injury Prevention
59. Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?
    Xin Chen, Zsuzsanna Gáborik, Qingcheng Mao, Jashvant D. Unadkat · 2024 · International Journal of Molecular Sciences
60. Effects of prenatal cannabinoid use on the monoamine system in the fetoplacental unit: A systematic review of animal and human studies
    Ramon Portillo, Tetiana Synova, František Štaud · 2025 · Drug and Alcohol Dependence
61. Pharmacokinetics and Bioavailability of Cannabinoids Administered via a Novel Orobuccal Nanoparticle Formulation (NanoCelle™) in Patients with Advanced Cancer
    Stephanie E. Reuter, Hayley B. Schultz, Andrew J. McLachlan, Jeremy David Henson, Luis Vitetta · 2025 · Cannabis and Cannabinoid Research
62. Orally consumed cannabinoids: the effect of carrier oil on acute tissue distribution in male C57BL/6 mice
    Cody A. C. Lust, Lyn M. Hillyer, Mitchell Pallister, Amanda Joyce Wright, Michael Armin Rogers, Erin M. Rock, Cheryl L. Limebeer, Linda A. Parker, David W.L. · 2025 · Journal of Cannabis Research
63. Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone‐Based Cannabinoid Receptor Type 2 Ligands
    Giulio Ragusa, Serena Bencivenni, Paula Morales, Tyra Callaway, Dow P. Hurst, Battistina Asproni, Stefania Merighi, Giovanni Loriga, Gerard Aime Pinna, Patricia H. Reggio et al. · 2018 · ChemMedChem
64. Human and rat microsomal metabolites of N-tert-butoxycarbonylmethamphetamine and its urinary metabolites in rat
    Hidenao Kakehashi, Takahiro Doi, Misato Wada, Tooru Kamata, Noriaki Shima, Akari Miyake, Atsushi Nitta, Ryutaro Asai, Shihoko Fujii, Shuntaro Matsuta et al. · 2021 · Forensic Toxicology
65. The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies
    Chloe P. O’Dell, Dawn S. Tuell, Darshan Shah, William L. Stone · 2022 · Frontiers in Bioscience-Landmark
66. Medical Cannabis Formulations
    Brian F. Thomas, Mahmoud A. ElSohly · 2015 · Elsevier eBooks
67. Marijuana’s Role in The Adolescent Population
    Thersilla Oberbarnscheidt, Norman Stanley Miller · 2017 · Journal of Addiction Research & Therapy
68. Cannabiskonsum zum Freizeitgebrauch
    Miriam Schneider, Chris M. Friemel, Rupert von Keller, Kristina Adorjan, Udo Bonnet, Alkomiet Hasan, Derik Hermann, Joseph Kambeitz, Dagmar Koethe, Ludwig Kraus et al. · 2018 · Springer eBooks
69. PHARMACOLOGY OF NOVAL CANNABINOIDS
    S. K. SUMITHA, VEENA S. PATTAMMADY, Sambathkumar Ramanathan · 2019 · International Journal of Pharmacy and Pharmaceutical Sciences
70. Disparity between Perceptual Fall Risk and Physiological Fall Risk in Older Cannabis Users: A Pilot Study
    Craig David Workman, Jacob J. Sosnoff, Thorsten Rudroff · 2021 · International Journal of Environmental Research and Public Health
71. Follow up: palmitic acid ester of tetrahydrocannabinol (THC) and palmitic acid diester of 11-hydroxy-THC – unsuccessful search for additional THC metabolites
    Michael Krämer, Cornelius Heß, Alexandra Maas, Burkhard Madea, András Bilkei‐Gorzó, Prakash Nidadavolu · 2021 · Drug Metabolism and Personalized Therapy
72. Impact of Low-Dose Dronabinol Therapy on Cognitive Function in Cancer Patients Receiving Palliative Care: A Case-Series Intervention Study
    Ditte Buchwald, Casper Schmidt, Dorte Buchwald, Kristina Iris Winter, Ivan Bo Nielsen, Kirsten Klostergaard, Dorte Melgaard, Steen Kåre Fagerberg, Peter Derek Christian Leutscher · 2023 · Palliative Medicine Reports
73. The Pharmacology of Delta-9-Tetrahydrocannabinol (THC)
    Leslie Lars Iversen · 2018 · Oxford University Press eBooks
74. Hochdosisdronabinoltherapie vs. Medizinalcannabisblüten
    Christoph Wendelmuth, Knud Gastmeier · 2019 · Der Schmerz
75. Marijuana and alcohol increase crash avoidance reaction time in a driving simulator test at blood concentrations below commonly-used per se ‘Cut-offs’ for Intoxication
    Alali Kawthar, Stewart Jessica, Taneja Rimzim, Edison Nwobi, Murdock Brianna, Tyiesha Head, Malone Ki-Jana, Mohammed Mohammed B, MaryAnne Stewart, McQueen Jamie et al. · 2020 · Journal of Addiction Medicine and Therapeutic Science
76. High Doses of Δ9-Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful Interactions
    Nevenka Kopjar, Nino Fuchs, Irena Brčić Karačonji, Suzana Žunec, Anja Katić, Goran Kozina, Ana Lucić Vrdoljak · 2020 · Clinical Drug Investigation
77. Physiological and Ethological Effects of Sativex, A Cannabis-based Medicine, Examined on Ants as Models
    Marie‐Claire Cammaerts, Roger Cammaerts · 2020 · Acta Scientific Pharmaceutical Sciences
78. Cannabinoids in chronic pain management: a skein to be untangled
    Flaminia Coluzzi · 2018 · Minerva Anestesiologica
79. Development of Liquid Chromatography-Tandem Mass Spectrometry Methods of Cannabinoids for Pediatric Patient Samples
    Stephanie Vuong · 2020 · HARVEST (University of Saskatchewan)
80. Prenatal exposure to THC vapor influences feeding, bodyweight and glucose metabolism under both basal conditions and following high fat diet
    Catherine Hume, Samantha L. Baglot, Lucia Javorcikova, Savannah H. M. Lightfoot, Jessica Scheufen, Matthew N. Hill · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
81. Understanding the Risk of CBN Degradation - A Novel use for OxySorbTM & CannaFreshTM Oxygen Absorbers in Cannabis Storage
    Simon Angelo Cichello · 2023 · Journal of Complementary Medicine & Alternative Healthcare
82. CANNABIS-DERIVED PHARMACEUTICAL PRODUCTS: THERAPEUTIC, PHARMACOKINETIC AND CLINICAL IMPLICATIONS - A COMPREHENSIVE REVIEW
    Ganga Srinivasan, Deepak Shukla · 2024 · INDIAN DRUGS
83. Uncovering mechanism of hepatotoxicity diseases caused by tetrahydrocannabinol based on novel network toxicology and experimental verification
    Tiantian Zou, Ruilin Zhang, Liping Hu, Genmeng Yang, Xuanyu Chen, Mengqing Wang, Tiantian Cheng, Shengjie Nie, Linlin Liu, Shijun Hong · 2025 · Scientific Reports
84. Bridging THC Knowledge Gaps for Safer Roads: A Call for Action
    Peizhi Li, Guohua An · 2025 · Clinical Pharmacology & Therapeutics
85. The influence of genetics on the endocannabinoid system gene expression and relevance for targeting reproductive conditions
    Keisuke Tanaka, Akwasi Atakora Amoako, Sally Mortlock, Peter A. W. Rogers, Sarah J. Holdsworth‐Carson, Jacqueline F. Donoghue, Wan Tinn Teh, Grant W. Montgomery, Brett David McKinnon · 2025 · Journal of Cannabis Research
86. Influence of cannabis and alcohol on motor vehicle injury severity in Canadian trauma centres: a prospective study
    Sarah M. Simmons, Madison Donoghue, Shannon Erdelyi, Herbert Chan, Christian Vaillancourt, Paul Atkinson, Floyd Besserer, David B. Clarke, Philip J. Davis, Raoul Daoust et al. · 2025 · Injury Prevention
87. Toward developing conceptual and operational definitions for research on driving under the influence of cannabis
    Sarah M. Simmons, Jeff K. Caird, Mark Asbridge, Bianca Boicu, Herbert Chan, Jeffrey Reynold Brubacher · 2025 · Transportation Research Part F Traffic Psychology and Behaviour
88. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models
    Margaret F. Bedillion, Catherine F. Moore, Elise M. Weerts, Caroline A. Arout, Hannah M. Harris, Margaret Haney · 2025 · Current topics in behavioral neurosciences
89. Analytical Approaches to Address Challenges in the Analysis of Cannabinoids in Vascular Matrices Using Mass Spectrometry
    Radwa S Moatamed, Robert B. Laprairie, Anas El‐Aneed · 2025 · Mass Spectrometry Reviews
90. Cannabis and Sudden Cardiac Death: A Case Series with Narrative Literature Review
    Vito Maria Goffredo, Michela Ferrara, Mariagrazia Calvano, Natascha Pascale, Aldo Di Fazio, Giuseppe Bertozzi · 2025 · Forensic Sciences
91. Cannabidiol metabolites identified by LC-QTOF after controlled dosing
    Svante Vikingsson, Ruth E. Winecker, Katherine Bollinger, Lawrance D. Mullen, Tory R. Spindle, Ryan G. Vandrey, Edward J. Cone, Lisa Davis, Ronald R. Flegel, Eugene D Hayes · 2025 · Journal of Analytical Toxicology
92. Comparative analysis of 105 datasets across species and tissues reveals differential transcriptomic responses to cannabinoids THC and CBD
    Ruoshui Liu, Thomas Kowal, Caden Chow, Tyler Olson, Emily Nguyen, Sen Yang, Jimin Lee, Hua “Linda” Cai, Xia Yang, Montgomery Blencowe · 2025 · Journal of Cannabis Research
93. Detecting cannabis use reduction through biochemical verification of urinary cannabinoids: An aggregated analysis of cannabis use disorder treatment trials examining average reductions and individual cut‐points
    Erin A. McClure, Brian Neelon, Rachel L. Tomko, Ashley N Dowd, Kevin Michael Gray, Aimee L. McRae‐Clark, Nathaniel L. Baker · 2025 · Addiction
94. Assessing the influence of CYP2C9 and CYP2C19 genotypes on the metabolism of CBD-cannabis after controlled single and repetitive consumption
    Janine Schulte, Leila Potzel, Priska Frei, Isabell Seibert, Kathrin Gerlach, Katja Mercer‐Chalmers‐Bender, Eva Scheurer, Henriette E. Meyer zu Schwabedissen, Iris Schulz · 2026 · International Journal of Legal Medicine
95. The psychoactive cannabinoid THC inhibits peripheral nociceptors by targeting NaV1.7 and NaV1.8 nociceptive sodium channels
    Yossef Maatuf, Ariel Iskimov, Alexander M. Binshtok, Avi Priel · 2026 · Neuropsychopharmacology
96. Urinary Δ9-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review
    Danielle McCartney, Chris Irwin, Jonathon Carl Arnold, Rebecca Gordon, Andrew J. McLachlan, Iain S. McGregor · 2026 · Pharmacological Research
97. Simultaneous analysis of Δ9-THC, Δ8-THC, CBD, and CBN in breath aerosols collected using cannabix technologies breath collection unit
    Shaza Deeb, Zaire E Fabian, Mikko Maatta, Pedro Fraccarolli, David A. Engelhart · 2026 · Journal of Analytical Toxicology
98. Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies
    Silvia Afonso, Joana Gonçalves, Ana Teresa Brinca, Luana M. Rosendo, Tiago Rosado, Ana Paula Duarte, Eugénia Gallardo · 2026 · Diseases
99. Prediction and Validation of Phase II Glucuronide Conjugates in Urine Using Combined Non-Targeted and Targeted LC–HRMS/MS Workflows and Their Validation for over 200 Drugs
    Camila Bardy, Luis Manuel Menéndez-Quintanal, Gemma Montalvo, Carmen García‐Ruiz, Begoña Bravo Serrano, José Manuel Matey · 2026 · Analytica—A Journal of Analytical Chemistry and Chemical Analysis
100. Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement
     Anushree Nagaraj, Ali Seyfoddin · 2026 · AAPS PharmSciTech